glaucoma

Drug therapies, delivery systems advance for glaucoma carePharmacologic products and devices in development continue to gain momentum in the glaucoma treatment armamentarium.
MIGS devices lead glaucoma surgical innovation in 2016A single event stood out in everyone’s mind when Ophthalmology Times asked experts to think back on the year in glaucoma surgery: the July 29 approval by the U.S. Food and Drug Administration (FDA) of the CyPass Micro-Stent.
Glaucoma 360 approaches disease from every angleResearch. Industry. Philanthropy. These three facets—each with a unique purpose—will come together for the 2017 installment of the annual Glaucoma Research Foundation (GRF) Glaucoma 360 meeting. The three-day event will occur Feb. 2 to 4, 2016.
Glaucoma micro-stent’s 2-year data promisingTake-home: With the approval of a new surgical device aimed at lowering IOP, surgeons explore benefits of micro-stent implantation.
Extended depth-of-focus IOLs may provide improved visual performanceAs your patients celebrate another birthday milestone, they are again back in your chair wondering why their reading glasses mysteriously disappear when they are out exploring life or why their arms are not as long as they used to be.
Effects of concurrent use of topical, oral beta blockersRecently, I received a progress note from a glaucoma surgeon concerning a patient whom he and I share. The patient is a 58-year-old African-American female with a longstanding history of primary open-angle glaucoma.
Managing the growing burden of glaucomaThe number of patients with glaucoma will rise dramatically in the future because of growth in both the size of the aged population and in demographic groups at high-risk for the disease. Ophthalmology, however, is not equipped to handle the increasing demand for services considering workforce projections and current models of care.
Biosensors in contact lenses can monitor IOP and diabetesWork is progressing on contact lenses that can monitor biomarkers in tear film for intraocular pressure, diabetes mellitus, and other health conditions.
Managing ocular surface disease in patients with glaucomaTreating ocular surface disease may have an impact on the effectiveness of glaucoma treatment. Inder Paul Singh, MD, offers some strategies used in practice.
Similarities seen in ocular protein deposits in glaucoma, dementiaThe latest findings in the similarities between protein deposits seen in the eyes of patients with glaucoma and those with dementia are highlighted.